XEVMPD and Product Information Service
Under Regulation 1235/2010/CE and Directive 2010/84/EU, Marketing Authorization (MA) Holders of medicinal products for human use are required to populate the European Medicines Agency’s (EMA) “eXtended EudraVigilance Medicinal Product Dictionary” (XEVMPD) with data pertaining to their EU-authorized medicines.
The XEVMPD has long served as the industry standard for coding substances and medicinal products reported in Individual Case Safety Reports (ICSRs), based on the information submitted by MA Holders in accordance with Article 57(2), second subparagraph, of Regulation (EC) No 726/2004.
The EMA is currently transitioning data from the XEVMPD to the new “Product Management Service” (PMS). This migration fulfils a regulatory mandate to adopt a new, ISO IDMP-compliant data format, significantly enhancing the quality, consistency, and traceability of information. This shift also facilitates key EMA-led digital transformation initiatives, such as the implementation of Electronic Product Information (ePI) and the adoption of web-based Application Forms.
As Companies prepare for data enrichment within the PMS, it is critical to ensure an accurate migration from the XEVMPD, verifying both the integrity and consistency of the source data.
Di Renzo Regulatory Affairs provides a specialized pharmacovigilance unit, featuring a dedicated team of experts proficient in data entry and the continuous maintenance of these essential regulatory databases.
